CHRISTIAN E MARTIN

Allopathic & Osteopathic Physicians|Family Medicine SHELBY, NC NPI 1346286366

General Payments — all program years on this page

$8,082.46

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 96
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,980.51 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Travel and Lodging $1,425.463
Food and Beverage $555.0514

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $1,810.807
Acerta Pharma LLC $57.264
PFIZER INC. $49.573
ABBVIE INC. $33.121
Novo Nordisk AS $15.871
Lilly USA, LLC $13.891

By program year

Program yearAmountRecords
2018 $212.0511
2019 $1,177.6812
2020 $212.4913
2021 $220.3816
2022 $140.689
2023 $4,138.6718
2024 $1,980.5117

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096682123 Novo Nordisk Inc $15.87 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104645875 AstraZeneca Pharmaceuticals LP $15.38 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104972755 ABBVIE INC. $33.12 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105229790 AstraZeneca Pharmaceuticals LP $13.32 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105365048 AstraZeneca Pharmaceuticals LP $13.82 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105453753 AstraZeneca Pharmaceuticals LP $14.74 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111644668 Amgen Inc. $17.09 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111644670 Amgen Inc. $155.02 02/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111644672 Amgen Inc. $275.00 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111644674 Amgen Inc. $562.74 02/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111644676 Amgen Inc. $707.70 02/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111644678 Amgen Inc. $86.90 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117319810 Amgen Inc. $6.35 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131007960 PFIZER INC. $18.40 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131671191 PFIZER INC. $16.89 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131856894 PFIZER INC. $14.28 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136119151 Lilly USA, LLC $13.89 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.